Literature DB >> 11248414

Sialomucin production in aberrant crypt foci relates to degree of dysplasia and rate of cell proliferation.

M Jenab1, J Chen, L U Thompson.   

Abstract

Aberrant crypt foci (ACF) are putative early preneoplastic lesions of colon cancer. To date, many different ACF parameters have been measured as indicators of degree of colon cancer risk. It has been suggested that ACF producing sialomucins (SIM) may be more advanced types of ACF than those producing sulphomucins (SUM), but little data are available to support this. The objective of this experiment was to see if SIM ACF, as observed in whole mount colons, are different from other ACF and surrounding normal colonic crypts in terms of their rate of cell proliferation and degree of dysplasia. Results showed that all ACF had a higher rate of cell proliferation than normal crypts and that SIM ACF had higher cell proliferation in the top regions of the crypt, higher phih index of cell proliferation, higher degree of dysplasia, greater size and increased degree of luminal alterations than SUM ACF. We conclude that SIM ACF, as observed in whole mount colons, have more alterations and are more advanced towards tumorigenesis than SUM ACF and may be a better predictor of colon cancer risk than other measures of ACF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248414     DOI: 10.1016/s0304-3835(00)00706-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Comparative DNA adduct formation and induction of colonic aberrant crypt foci in mice exposed to 2-amino-9H-pyrido[2,3-b]indole, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, and azoxymethane.

Authors:  Sangyub Kim; Jingshu Guo; M Gerald O'Sullivan; Daniel D Gallaher; Robert J Turesky
Journal:  Environ Mol Mutagen       Date:  2016-01-06       Impact factor: 3.216

2.  The Pil3 pilus of Streptococcus gallolyticus binds to intestinal mucins and to fibrinogen.

Authors:  Mariana Martins; Constance Porrini; Laurence du Merle; Camille Danne; Catherine Robbe-Masselot; Patrick Trieu-Cuot; Shaynoor Dramsi
Journal:  Gut Microbes       Date:  2016-09-22

3.  Hesperetin exerts dose dependent chemopreventive effect against 1,2-dimethyl hydrazine induced rat colon carcinogenesis.

Authors:  Selvaraj Aranganathan; Jayabal Panneer Selvam; Namasivayam Nalini
Journal:  Invest New Drugs       Date:  2008-07-22       Impact factor: 3.850

4.  Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.

Authors:  Aida U Jawhari; Andrea Buda; Michelle Jenkins; Khurram Shehzad; Catherine Sarraf; Masao Noda; Michael J G Farthing; Massimo Pignatelli; Josephine C Adams
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

Review 5.  Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer.

Authors:  Ewa Pasquereau-Kotula; Mariana Martins; Laetitia Aymeric; Shaynoor Dramsi
Journal:  Front Microbiol       Date:  2018-04-03       Impact factor: 5.640

6.  Aberrant crypt foci: the case for inclusion as a biomarker for colon cancer.

Authors:  Michael J Wargovich; Vondina R Brown; Jay Morris
Journal:  Cancers (Basel)       Date:  2010-09-16       Impact factor: 6.639

7.  Djulis (Chenopodium Formosanum) Prevents Colon Carcinogenesis via Regulating Antioxidative and Apoptotic Pathways in Rats.

Authors:  Chih-Wei Lee; Hong-Jhang Chen; Gui-Ru Xie; Chun-Kuang Shih
Journal:  Nutrients       Date:  2019-09-10       Impact factor: 5.717

8.  Lactobacillus acidophilus-Fermented Germinated Brown Rice Suppresses Preneoplastic Lesions of the Colon in Rats.

Authors:  Sing-Chung Li; Han-Pei Lin; Jung-Su Chang; Chun-Kuang Shih
Journal:  Nutrients       Date:  2019-11-09       Impact factor: 5.717

9.  Synbiotic Combination of Djulis (Chenopodium formosanum) and Lactobacillus acidophilus Inhibits Colon Carcinogenesis in Rats.

Authors:  Chih-Wei Lee; Hong-Jhang Chen; Yu-Hua Chien; Shih-Min Hsia; Jiann-Hwa Chen; Chun-Kuang Shih
Journal:  Nutrients       Date:  2019-12-30       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.